Researchers have shown for the first time that a crucial interface in a protein that drives cancer growth could act as a target for more effective treatments.
Breathing New Life into Diagnostics: Plasmion’s SICRIT® Technology
Revolutionizing Non-Invasive Diagnostics with Plasmion’s SICRIT Breath Analysis.